Customize
Quick Links
Past Events

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 19.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Supporters

This activity is supported by educational grants from Celgene Corporation, Eisai Inc., Genentech, Lilly USA, LLC, and Novartis Pharmaceuticals Corporation.
About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

12th Annual International Congress on the Future of Breast Cancer®

12th Annual International Congress on the Future of Breast Cancer®


Agenda

Thursday, July 18
7:30 am Registration and Continental Breakfast  
Morning Session
8:30 am Welcome and Introductions Joyce A. O'Shaughnessy, MD
Controversies in Managing ER+ Breast Cancer
8:45 am Is It Stage or Is It Biology? Kathy S. Albain, MD, FACP
9:15 am Why Are Some ER+ Breast Cancers PR-negative? Carol Lange, PhD
9:35 am Who Should Be Offered Anti-Androgen Receptor Therapy? Suzanne Fuqua, PhD
9:55 am Duration of Adjuvant Endocrine Therapy: What Have ATLAS and aTTom Taught Us? Christy A. Russell, MD
10:15 am ER+ BC Controversies, Lobular Breast Cancers, Therapeutic Considerations Joseph Sparano, MD
10:35 am Break  
11:00 am Who Benefits From PI3K/mTOR Blockade? Hope S. Rugo, MD
11:20 am Novel Therapies for Virulent ER+ Disease Richard Finn, MD
11:50 am Case Discussions from Faculty Practices  
12:30 pm Break for Lunch (lunch on own)  
Afternoon Session - Controversies in Locoregional Breast Cancer Therapy
1:55 pm Altered Fractionation: When Is It Appropriate? Jennifer R. Bellon, MD
2:15 pm Coordinating Radiation and Reconstruction Alice Ho, MD
2:35 pm Break  
3:00 pm Sentinel Lymph Node Biopsy and Neoadjuvant Therapy Eleftherios Mamounas, MD, MPH, FACS
3:20 pm Is Systemic Therapy Effective After Locoregional Recurrence? Irene L. Wapnir, MD
3:50 pm Case Discussions from Faculty Practices  
4:25 pm Adjourn  
5:00 pm Welcome Reception (Exhibit Hall)  
 
Friday, July 19
7:00 am Continental Breakfast  
Sunrise Session - An Open Case Discussion
7:30 am Controversial Cases From Your Practices Moderator: Joyce O'Shaughnessy, MD
Elizabeth Mittendorf, MD, PhD
Torsten Nielsen, MD, PhD, FRCPC
Sandra Swain, MD, FACP
8:00 am Discussion  
8:20 am Sunrise Session Adjourn  
Morning Session
8:30 am Welcome and Introductions  
8:35 am The New Guidelines for MBC Manangement Hope Rugo, MD
Controversies in Managing HER2+ Breast Cancer
9:05 am Adjuvant and Neoadjuvant HER2-Targeted Therapy: Best Practices  Debu Tripathy, MD
9:25 am Data-Driven Management of HER2+ MBC Joyce O'Shaughnessy, MD
9:45 am The Role of HER1 and HER3 in HER2+ Breast Cancer Brent Rexer, MD, PhD
10:05 am Break  
10:30 am HER2-Targeted Vaccine Therapies Elizabeth Mittendorf, MD, PhD
11:00 am Case Discussions from Faculty Practices  
Evolving Diagnostics: Prime Time or Not?
11:30 am Evolving Clinical Utility of CTCs Minetta Liu, MD 
11:50 am Ki67: The Good, the Bad, and the Clinical Utility Torsten O. Nielsen, MD, PhD, FRCPC
12:10 pm Panel Discussion  
12:30 pm Break for Lunch (lunch on own)  
Afternoon Session
1:50 pm Lessons from The Cancer Genome Atlas for ER+ Breast Cancer Matthew Ellis, M.B., B.Chir., Ph.D.
Practical Updates for Monday Morning
2:20 pm Optimizing Non-Anthracycline Adjuvant Therapy Stephen E. Jones, MD
2:40 pm Break  
3:05 pm Osteoclast-Targeted Therapy, Forever? Frankie Ann Holmes, MD, FACP
3:35 pm Case Discussions from Faculty Practices  
4:15 pm Adjourn  
 
Saturday, July 20
7:00 am Continental Breakfast  
Sunrise Session - Health Care Reform: Implications for Oncology Practice
7:30 am Washington Update - Examining the Oncology Landscape Post-Healthcare Reform Ben Jones
8:00 am Discussion  
8:20 am Sunrise Session Adjourn  
Morning Session
8:30 am Welcome and Introductions  
Controversies in the Management of Triple-Negative Breast Cancer
8:45 am When to Consider Platinum-Based Therapy Melinda L. Telli, MD
9:05 am The Glucocorticoid Receptor: Friend or Foe? Suzanne Conzen, MD
9:25 am Novel Preoperative Strategies for TNBC Ingrid A. Mayer, MD, MSCI
9:45 am Novel Therapies for Brain Metastases Carey Anders, MD
10:05 am Break  
10:30 am Therapeutic Advances in TNBC Joyce A. O'Shaughnessy, MD
10:50 am Targeting the Metastatic Machinery Lori J. Goldstein, MD
11:10 am Pregnancy and Breast Cancer Sandra M. Swain, MD, FACP
11:40 am Case Discussions from Faculty Practices  
12:20 pm Break for Lunch (lunch on own)  
Afternoon Session - Community Oncology in the Era of Genomic Oncology
1:35 pm NCI-FDA Efforts to Accelerate Availability of Novel Agents Jo Anne Zujewski, MD
1:55 pm Is There Clinical Utility in Genomic Profiling of MBCs? Stefan Gluck, MD, PhD, FRCPC
2:15 pm Environmental Breast Carcinogenesis David Euhus, MD
2:35 pm Panel Discussion  
2:55 pm SCOTUS Patent Decision and the Future of Genetic Testing Ellen Matloff, MS
3:15 pm Closing Comments Joyce A. O'Shaughnessy, MD
3:20 pm Adjourn  







Become a Member

Forgot Password?
Filter By